Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues
- PMID: 100492
Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues
Abstract
Human factor VIII/von Willebrand factor protein containing 120 +/- 12 nmol of sialic acid and 135 +/- 13 nmol of galactose/mg of protein was digested with neuraminidase. The affinity of native factor VIII/von Willebrand factor and its asialo form for the hepatic lectin that specifically binds asialoglycoproteins was assessed from in vitro binding experiments. Native factor VIII/von Willebrand factor exhibited negligible affinity while binding of the asialo derivative was comparable to that observed for asialo-alpha1-acid glycoprotein. Incubation of asialo-factor VIII/von Willebrand factor with Streptococcus pneumoniae beta-galactosidase removed only 62% of the galactose but abolished binding to the purified hepatic lectin. When the asialo derivative was incubated with purified beta-D-galactoside alpha2 leads to 6 sialyltransferase and CMP-[14C]NeuAc, only 61% of the galactose incorporated [14C]NeuAc. From the known specificites of these enzymes, it is concluded that galactose residues important in lectin binding are present in a terminal Gal/beta1 leads to 4GlcNAc sequence on asialo-factor VIII/von Willebrand factor. The relative ristocetin-induced platelet aggregating activity of native, asialo-, and agalacto-factor VIII/von Willebrand factor was 100:38:12, respectively, while procoagulant activity was 100:100:103.
Similar articles
-
Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.Thromb Haemost. 1985 Jun 24;53(3):390-5. Thromb Haemost. 1985. PMID: 2864750
-
Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.J Clin Invest. 1978 Aug;62(2):496-9. doi: 10.1172/JCI109152. J Clin Invest. 1978. PMID: 307560 Free PMC article.
-
Studies on factor VIII-related protein. IV. Interaction of galactose-specific lectins with human factor VIII/Von Willebrand factor.Biochim Biophys Acta. 1980 Jun 26;623(2):402-11. doi: 10.1016/0005-2795(80)90269-x. Biochim Biophys Acta. 1980. PMID: 6772231
-
The factor VIII complex: structure and function.Blood. 1981 Jul;58(1):1-13. Blood. 1981. PMID: 6165414 Review.
-
[Structure and function of the factor VIII/von Willebrand factor complex].Z Gesamte Inn Med. 1990 Mar 1;45(3):65-8. Z Gesamte Inn Med. 1990. PMID: 2159676 Review. German.
Cited by
-
Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.J Clin Invest. 1981 Aug;68(2):321-8. doi: 10.1172/jci110259. J Clin Invest. 1981. PMID: 6790574 Free PMC article.
-
Perioperative management of patients with von Willebrand's disease.Can J Anaesth. 1990 Apr;37(3):341-7. doi: 10.1007/BF03005587. Can J Anaesth. 1990. PMID: 2182206 Review.
-
Glycogen storage disease type Ib: familial bleeding tendency.Eur J Pediatr. 1984 Nov;143(1):7-9. doi: 10.1007/BF00442739. Eur J Pediatr. 1984. PMID: 6334607
-
Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands.Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10042-7. doi: 10.1073/pnas.142005099. Epub 2002 Jul 3. Proc Natl Acad Sci U S A. 2002. PMID: 12097641 Free PMC article.
-
Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function.J Cell Biol. 1982 Nov;95(2 Pt 1):632-40. doi: 10.1083/jcb.95.2.632. J Cell Biol. 1982. PMID: 6815213 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources